Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Organogenesis Holdings Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 120 | 1 | 136 | +17 |
| Shares | 62.6M | 338.1K | 64.9M | +2.72M (+4.4%) |
| Value | $200.2M | $1.08M | $280.6M | +$81.5M (+40.9%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (28)
Institutions that held Organogenesis Holdings Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (11)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Gsa Capital Partners LLP | 354,154 | $1.13M |
| Savant Capital, LLC | 64,623 | $206.8K |
| HRT Financial LP | 56,408 | $180.0K |
| Virtus Investment Advisers, Inc. | 49,000 | $156.8K |
| Prelude Capital Management, LLC | 10,200 | $32.6K |
| Estabrook Capital Management | 10,000 | $32.0K |
| R Squared Ltd | 4,260 | $13.6K |
| SRS Capital Advisors, Inc. | 2,311 | $7.40K |
| Toth Financial Advisory Corp | 1,001 | $3.20K |
| Skopos Labs, Inc. | 705 | $2.26K |
| IFP Advisors, Inc | 9 | $29 |
Not filed for Q1 2025 yet (1)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 338,056 | $1.08M |